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Studies have shown that embryonic stem (ES) cells can be successfully differentiated into liver cells, 
which offer the potential unlimited cell source for a variety of end-stage liver disease. In our study, in 
order to induce mouse ES cells to differentiate into hepatocyte-like cells under chemically defined 
conditions, ES cells were induced by sodium butyrate as inducer for 7 days in the first phase, followed 
by the combination of hepatocyte growth factor and dexamethasone as inducers for 12 days in the 
second phase based on an adherent culture system with a two-step induction. The results from the 
morphology, gene expression, protein molecular markers and cell function of ES-D3 cells derived 
hepatocyte-like cells demonstrated that mES cells can be differentiated efficiently in vitro to functional 
hepatocytes under chemically defined conditions, which might be useful as an in vitro system for 
hepatocyte transplantation therapy and toxicity screening in drug discovery.  
 






The liver is the major organ that provides multiple 
metabolic functions critical for the maintenance of 
homeostasis. One of the major causes of morbidity and 
mortality worldwide is liver failure or end-stage liver 
diseases for which orthotopic liver transplantation (OLT) 
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transplantation has several limitations, including high 
cost, side effects for the donor and requirement for 
immunosuppression, especially, the shortage of organ 
donors which limit the use of this therapeutic modality. 
During the last decade, hepatocyte transplantation 
therapy provides an alternative therapy strategy for liver 
failure or end-stage liver diseases (Tanaka et al., 2006). 
To enhance the potential for this approach, hepatocyte 
transplantation therapy requires a renewable cell source 
of functional hepatocytes in vitro. One of the most 
promising potential sources of functional hepatocytes is 
from embryonic stem (ES) cell or induced pluripotent 
stem cells (iPS).  
ES cells and iPS cells are pluripotent cells and capable 
of giving rise to most tissues of the organism, including 
the germ line during development. ES cells or iPS cells 
have shown promise for use in regenerative medicine 
and regarded as a powerful resource for cell replacement 
therapy including its possible application for treating liver 
diseases. ES cell-derived or iPS cell-derived hepatocytes 
would   be   useful   as   a   source   of   material   for  cell  










transplantation, bioartificial liver (BAL) support devices, 
studies on hepatocyte biology and hepatitis viruses and 
drug testing. Previous studies indicated that ES cells 
could be differentiated into hepatocyte-like cells 
(Miyashita et al., 2002; Chinzei et al., 2002; Matsumoto et 
al., 2008; Mizumoto et al., 2008; Shiraki et al., 2008). 
Presently, iPS cell-derived hepatocytes have been 
reported (Si-Tayeb et al., 2010; Sullivan et al., 2010; Li et 
al., 2010; Gai et al., 2010; Liu et al., 2010). However, ES 
cells diffe-rentiation into hepatocyte is in infancy. We can 
differentiate ES cells into hepatocyte by simulating the 
mechanism of liver development, employing the related 
cytokines or compounds, genetic modification and co-
culture, which is complex technically, inefficient and 
costly, and most of the protocols currently used were 
devised to differentiate ES cells into hepatocyte by using 
embryoid bodies (EB) that may result in low yield or low 
purity of functional hepatocytes, therefore, the direct 
hepatic differentiation from an ES monolayer without 
using embryoid bodies is most promising (Teratani et al., 
2005). 
In this study, we established a novel procedure to 
differentiate ES cells into functional hepatocyte-like cells 
employing sodium butyrate (NaB) as inducer for 7 days in 
the first phase, followed by the combination of hepatocyte 
growth factor (HGF) and dexamethasone (Dex) as 
inducer for 12 days in the second phase using an 
adherent culture system with a two-step induction. The 
NaB is an epigenetic modulator and can direct the 
differentiation of ES cells into hepatic progenitors (Zhou 
et al., 2007; Ren et al., 2010). HGF and Dex play an 
important role in the maturation of hepatocytes (Ong et 
al., 2006). Our strategy is simple, efficient and relatively 
economical, based on two-step induction with NaB and 
cytokines under chemically defined conditions, and might 
provide a useful model and a potential source for liver 
development study and hepatocytes transplantation.  
 
 
MATERIALS AND METHODS 
 
mES cells culture 
 
Undifferentiated ES-D3 cell was maintained on mitomycin C-treated 
mouse embryonic fibroblast (MEF) feeder cells in knockout 
Dulbecco’s modified Eagle’s medium (KD, Gibco), an optimized 
DMEM for ES cells, supplemented with 15% knockout serum 
replacement (KSR, Gibco), 1 mmol/L glutamine (Gibco), 0.1 mmol/L 
β-mercaptoethanol (Gibco), 100 mM/L nonessential amino acids 
(Sigma), 100 mg/ml penicillin and 100 mg/ml streptomycin (Sigma). 
To help retain ES cells in an undifferentiated status, we added 1000 
U/ml recombinant mouse leukemia inhibitory factor (mLIF, 
Chemicon) to the culture medium.  
MEF feeder cells were isolated from KM mice at embryo day 13.5 
and cultured at 37°C and 5% CO2. At approximately 80% 
confluence, the feeder cells were incubated with 10 µg/ml 
mitomycin C (Sigma) for 2.5 h and washed six times with PBS 
(Gibco). Then the ES cells were seeded. Medium was changed 
every day until plates were confluent. Cells were dissociated using 
TrypLE Express (Gibco), and passage of the ES cells every 3 days 





Differentiation of ES cells into hepatocytes was carried out as 
described in Figure 1. Before initiating differentiation, ES cells were 
trypsinized into single cell suspension and cultured onto 0.1% 
gelatin (Sigma) coated plates (Corning) without the feeder layer. 
Residual feeder cells could be removed by combination of 
differential adhesion and simple passage. To direct the 
differentiation of ES cells into hepatocytes in vitro (group 2, G2), 
medium was changed to ES differentiation medium (ES cells 
medium without mLIF), supplemented with 3 mM sodium butyrate 
(NaB, Sigma) for 7 days. Then, cells were further cultured in ES 
differentiation medium containing 20 ng/ml recombinant mouse 
hepatocyte growth factor (rMuHGF, R&D Systerms) and 0.1 µM 
dexamethasone (Dex, Sigma) for another 12 days. Differentiated 
cells were passaged upon achieving 90% confluence. 
Spontaneously, differentiation group (group 1, G1) was used as a 
negative control that the cells of this group are treated by ES cells 
medium without mLIF during induction. 
 
 
Transmission electron microscopy observation 
 
Cell suspensions (1 x 10
7 
cells/ml) were centrifuged, the medium 
discarded, the cells fixed with 0.25% glutaraldehyde in PBS 
(pH 7.2) at 25°C for 2 h, then post-fixed with 1% OsO4, dehydrated 
in a graded series of ethanol solutions, infiltrated by propylene 
oxide, and finally embedded in epon. Ultrathin sections of the 
resulting sample were counterstained with 4% uranyl acetate, as 
well as lead citrate, and observed using H-7650 Transmission 
Electron Microscope (Hitachi High-Technologies Co., Japan). 
 
 
Hepatic specific gene expression analysis by real-time 
polymerase chain reaction (RT-PCR) 
 





 RNA Mini Kit (Invitrogen) according to the manu-
facturer’s protocol. 2 µg RNA sample was used to synthesize cDNA 
followed by PCR amplification using Thermocycler (TaKaRa 
Biotechnology Co Ltd). The PCR conditions were as follows: a first 
step of 5 min at 95°C, a second step of 30 cycles for 30 s at 95°C, a 





of 7 min at 72°C. Adult mouse liver was used as positive control. 






C-3′), 484 bp; PCR products then were subjected to electrophoresis 
in 2% agarose gels and stained with ethidium bromide. 
 
 
Immunostaining assay  
 
For immunostaining assay, cells were washed with PBS for 3 times 
respectively. Then the cells were fixed with pre-colded 4% 
paraformaldehyde (freshly prepared) for 15 min at room 
temperature. After aspirating the fixative, cells were washed three 
for 10 min each time with PBS. Then cells were incubated with 
TPBS (PBS containing 0.25% TritonX-100) for 10 min, followed by 
washing for 3 times for 5 min each time with PBS. Non-specific 
binding was blocked with TPBS containing 5% bovine serum 
albumin (BSA) for 30 min at room temperature. The cells were then 
incubated with primary antibody (AFP, cell signaling, USA 1:100; 
ALB, Abcam, UK, 1:100; CK8 and 18, Bioworld, USA, 1:100) diluted 
with 1% BSA in TPBS containing 5% BSA at 4°C. The cells were 
then washed three times with TPBS and incubated with appropriate 
fluorophore-labeled secondary antibodies: TRITC-labeled Goat 
Anti-Mouse IgG (1:100, Bioworld), FITC-labeled Goat Anti-Rabbit 
IgG (1:100, Bioworld) for 1 h at room temperature away from light. 
After washing with TPBS three times, nuclei were counterstained 
with 1 ug/ml 4',6-diamidino-2-phenylindole (DAPI, Roche) for 1 min, 




Periodic acid solution (PAS) reaction 
 
Cells were fixed with 4% phosphate buffered polyformalin solution 
for 3~5 min, and then washed three times with PBS. Fixed cells 
were exposed to 100 µl of periodic acid solution per well for 10 min. 
After rinsing with distilled water, 100 µl of Schiff’s reagent was 
added per well and cells were exposed for 10~20 min (incubation 
away from light). After removing the Schiff’s reagent, 100 µl of acid 
sulfite solution was added per well for 1 min, then washing with 
distilled water to remove the reagent for 10 min and examined by 
Zeiss microscope.  
 
 
Indocyanine green uptake assay 
 
After washing the culture cells with PBS, Indocyanine Green (ICG, 
Sigma) solution was added to the plates at a final concentration of 1 
mg/ml and incubated at 37°C for 60 min, then rinsed three times 
with PBS and the dishes were refilled with medium. ICG was 
completely eliminated from the cells 9 h later. The uptake and 
secretion of ICG is a specific function of hepatocytes. 
 
 
Measurement of differentiation ratio 
 
In this study, the hepatic differentiation ratio was determined by 
evaluating the percentages of ALB-positive cells in the differentiated 
cells. We randomly picked 6 wells from each  group  and  5  images 
from each well. ALB-positive cells and total cells counterstained 
with DAPI were counted using Zeiss fluorescence microscope. The 
values from each well were averaged to obtain a mean ± S.D. 






Data were expressed as mean ± S.D. Statistical analysis were 
performed using the Statistical Package for the Social Sciences 
(SPSS) program. The significant differences between the groups 
were assessed by one-way analyses of variance (ANOVA) with 





Establishing mES cells feeder-free culture system  
 
Undifferentiated mESC-D3 cell was maintained on 
mitomycin C-treated feeder cells, which possess the 
normal characteristics of morphology and active prolife-
ration (Figure 2A). We cultured mES-D3 cells in serum-
free and feeder-free culture system by the combination of 
gelatin coating, KD and KSR. The method of combination 
of differential adhesion and simple passage could remove 
the feeder cells effectively (Figure 2B), which laid the 
foundation for the follow-up differentiation. 
 
 
Morphologic observation during differentiation  
 
Observation of light microscopy showed that the mESC-
D3 cell gradually differentiated into hepatocyte-like cells 
during differentiation (Figure 3). Examination with 
transmission electron microscopy revealed that the mES 
cells derived hepatocyte-like cells were similar to hepa-
tocytes from a morphological viewpoint with abundant 
microvilli, numerous mitochondria, lipid droplets, rough 
endoplasmic reticulum, well-developed Golgi apparatus 
and occluding (tight) junctions normally present on the 
apical domain of hepatocytes (Figure 4). These results 
indicated that the mES cells derived hepatocyte-like cells 




Detection of hepatic specific genes by RT-PCR 
 
We detected the expression of some marker genes of 
ES-D3 cells derived hepatocyte-like cells by RT-PCR. 
The results showed that the ES-D3 cells derived 
hepatocyte-like cells expressed marker genes of AFP, 
ALB, TTR and AAT, the cells of spontaneous differen-
tiation slightly expressed marker genes of AFP and ALB, 
but late markers TTR and AAT were not expressed 
(Figure 5). The results indicated that the ES-D3 cells 
derived hepatocyte-like cells possess the gene 
expression characteristics of hepatocyte and comprised 
of hepatocyte-like cells with different stages of maturity.  
 
 
Detection of hepatic-associated protein marker 
 
The results of immunofluorescence analysis showed that  






Figure 2. Culture of ES cell on feeder layers and gelatin (x100) (A) ES cell clone on feeder layers; (B) The 3rd passage of ES 












Figure 4. TEM images of induced cells (×10000). Er: rough endoplasmic 





the ES-D3 cells derived hepatocyte-like cells express 
hepatocyte-specific marker proteins ALB, AFP, CK8 and 
CK18, while in the spontaneous differentiation, group of 
some cells also expressed ALB and AFP, but CK8 and 
CK18 were not expressed (Figure 6).  
Cell function analysis 
 
PAS staining was performed to examine glyco-
gensynthesis and storage, one of the characteristic 
functions of hepatocytes. After 19 days  of  differentiation,  

















a number of cells of G2 group were consistently positive 
for PAS stain, while many cells of G1 group were 
negative or slight staining (Figure 7). In addition, the ICG 
metabolism of cultured cells was also examined. Results 
showed that the ES-D3 cells derived hepatocyte-like cells 
of differentiation groups possess the metabolic function of 
ICG, while only a small number of cells in spontaneously 
differentiated group possess the metabolic function of 
ICG (Figure 8). These results suggested that the ES-D3-
Hep cells have hepatocyt specific cell function. 
 
 
Differentiation ratio comparison 
 
Differentiation rate of hepatocyte was determined by 
evaluating the percentages of ALB-positive cells in the 
differentiated cells. Approximately, 37.27% of the cells 
expressed the hepatic marker ALB by day 19 of culture in 
differentiation groups. Meanwhile, differentiation rate of 
spontaneous differentiation group is 8.25%, the difference 





ES cells have been regarded as a new cell source for cell 
replacement therapy. Establishing an effective technology 
of differentiation is an important direction of ES cells 
research, which provided the desired cell source for the 
repair of tissue injury and disease. Recently, differen-
tiation of hepatocytes from ES cells has been reported 
using either in  vitro,  in  vivo  differentiation  protocols,  or 













Figure 8. ICG uptake/excretion test (x200).Ability examination of 





protocols combining both approaches because the liver 
plays a major role in metabolism and has multiple 
functions, including glycogen storage, decomposition of 
red blood cells, plasma protein synthesis, and detoxi-
fication. A number of studies have demonstrated the 
feasibility of differentiating ES cells into the hepatic 
lineage (Soto-Gutierrez et al., 2006; Gouon-Evans et al., 
2006; Drobinskaya et al., 2008). 
Although, hepatocytes derived from ES cells promise a 
potential for treating liver or liver-related diseases. Most 
of the protocols currently developed to induce the hepatic 
differentiation from ES cells were devised by using 
embryoid bodies. It is time-consuming and may result in 
low yield and purity of functional hepatocytes. A previous 
study has demonstrated that hepatocyte-like cells could 
be directly induced from human ES cells by using a 
combination of cytokines (Hay et al., 2007). However, the 
direct hepatic differentiation of ES cells still remains a 
challenge and needs to be further developed. Based on 
chemically defined serum-free culture system of the 
combination of KD and KSR, we used the method of 
combination of differential adhesion and simple passage 
to remove feeder cells, which laid the foundation for the 
follow-up differentiation.  
Epigenetic modification is considered to be the main 
mechanism of cell differentiation involving in gene 
expression regulation and can be used as induction 
differentiation strategy. Histone acetylation is considered 
to be one of the most important epigenetic modification 
regulating gene expression, which is largely controlled by  



























Histone deacetylase (HDAC) inhibitors including NaB, a 
short-chain fatty acid. It is reported that NaB could induce 
growth arrest, differentiation, and apoptosis in a number 
of cancer cells (Giuliano et al., 1999; Joseph et al., 2004). 
Previous study have showed that sodium butyrate could 
differentiate ESCs into hepatic progenitor cells 
(Rambhatla et al., 2003; Zhou et al., 2007), and depend 
on the concentration and exposure time (Ren et al., 
2010). In addition, HGF has been shown to control the 
proliferation of fetal liver cells and support fetal 
hepatocytes during hepatogenesis (Uehara et al., 1995; 
Schmidt et al., 1995; Shelly et al., 1989). Meanwhile, 
glucocorticoids was reported to modulate the proliferation 
and function of adult hepatocytes (Kinoshita and 
Miyajima, 2002) and found to be involved in hepatic 
maturation. Consequently, HGF and Dex are core factor 
for the maturation of hepatocytes (Ong et al., 2006). 
In our study, we used 3M NaB as inducer for 7 days to 
differentiate ES cells into hepatic progenitor cells in the 
first phase, followed by the combination of HGF and Dex 
as inducer for 12 days to promote the maturation and 
proliferation and of hepatocytes in the second phase. The 
results from the morphology, gene expression, protein 
molecular markers and cell function of ES-D3 cells 
derived hepatocyte-like cells demonstrated that mES 
cells can be differentiated efficiently in vitro to functional 
hepatocytes under chemically defined conditions. About 
37.27% of the mouse ES cells could be manipulated to 
differentiate into ALB-positive cells and the hepatic 
differentiation ratio in differentiated cells was much higher 
than that in spontaneously differentiation group. This 
simple, efficient and relatively economical method may be 
useful as an in vitro system for hepatocyte transplantation 
therapy and toxicity screening in drug discovery, while 
further studies are needed to elucidate the detailed 
molecular mechanism, and sort the desired cells to 
perform in vivo experiments to further test cell 
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